Anaplastic large cell lymphoma (ALCL) is a type of non-Hodgkin lymphoma characterized by the presence of anaplastic large cells. The ALK-positive variant is associated with a specific genetic alteration that influences treatment response and prognosis. Intra-abdominal lymph node involvement indicates a more advanced disease stage, necessitating accurate coding with ICD-10 Code C84.63 for effective diagnosis, documentation, billing, and public health reporting.
ICD-10 Code C84.63 specifically identifies Anaplastic large cell lymphoma, ALK-positive, with involvement of intra-abdominal lymph nodes. This code is utilized in clinical documentation and billing to denote the presence of this aggressive lymphoma variant, ensuring appropriate treatment planning and resource allocation.
Anaplastic large cell lymphoma, ALK-positive, is a hematological malignancy that arises from T-cells and is characterized by the expression of the anaplastic lymphoma kinase (ALK) gene. This subtype often presents with advanced disease, including intra-abdominal lymph node involvement, which requires prompt medical intervention.
ICD-10 Code C84.63 is integral in SOAP notes for documenting the diagnosis of Anaplastic large cell lymphoma, ALK-positive, with intra-abdominal lymph node involvement. It aids in capturing the clinical picture, guiding treatment decisions, and ensuring accurate billing in both acute and chronic care settings.
In SOAP notes, ICD-10 Code C84.63 connects subjective patient reports and objective clinical findings to a formal diagnosis of Anaplastic large cell lymphoma, ALK-positive. This code is essential for ensuring continuity of care, supporting billing processes, and meeting EHR documentation standards.
The management of Anaplastic large cell lymphoma, ALK-positive, requires urgent medical attention, often necessitating hospitalization for intensive treatment.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C84.63 is crucial for billing in hospital, ER, or infectious disease care settings, ensuring accurate reimbursement for services rendered.
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push, single or initial substance. |
| 99223 | Initial hospital care, typically 70 minutes or more. |
| 85025 | Complete blood count with automated differential white blood cell count. |
Common Questions About Using ICD-10 Code C84.63 for Anaplastic large cell lymphoma, ALK-pos, intra-abd nodes
What are the common symptoms of Anaplastic large cell lymphoma?
Common symptoms include swollen lymph nodes, unexplained weight loss, fever, and night sweats. Patients may also experience abdominal pain if intra-abdominal nodes are involved.
How is Anaplastic large cell lymphoma diagnosed?
Diagnosis typically involves a combination of physical examination, imaging studies, and biopsy to confirm the presence of anaplastic large cells and ALK positivity.
What treatments are available for Anaplastic large cell lymphoma?
Treatment options include chemotherapy, targeted therapy with ALK inhibitors, and supportive care to manage symptoms and side effects.
Is Anaplastic large cell lymphoma curable?
The prognosis varies based on factors such as age, stage at diagnosis, and response to treatment. Many patients achieve remission with appropriate therapy.
Clinical Notes
SOAP notes
DAP notes
AI medical notes